EpSSG (European Soft Tissue Sarcoma Study Group) Protocol for Non-Metastatic Rhabdomyosarcoma in Children

Phase 4

• Conditions: Rhabdomyosarcoma

• Registration Number: NCT00339118
• Lead Sponsor: Sheba Medical Center

Brief Summary

The purpose of the study is achieve standardization treatment of low and intermediate risk rhabdomyosarcoma patients, with an attempt to improve treatment results in high and very high risk patients by the addition of doxorubicin as induction treatment and at the maintenance phase.

Detailed Description

Not available

Study Timeline

• Status Verified: 2006-06
• Study First Submitted: 2006-06-19
• Study First Submitted QC: 2006-06-19
• Last Update Submitted: 2006-06-19
• Study First Posted: 2006-06-20
• Last Update Posted: 2006-06-20

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• child
• non metastatic rhabdomyosarcoma
• adequate heart, kidney, liver function

Exclusion Criteria

• age over 21 years, under 6 months
• metastatic disease
• heart, kidney, liver disease

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
event free survival
overall survival